biosyn Arzneimittel GmbH is a pharmaceutical and biotech company headquartered in Fellbach. biosyn specializes in trace elements, is a global market leader for high-dose selenium injections, as well as a developer and operating company of two worldwide unique GMP active ingredient productions. In addition, biosyn is also active in the biotech area with a glycoprotein, isolated from Megathura crenulata (also commonly known as the Giant Keyhole Limpet), a sea snail species found in California. 70 percent of the turnover is generated outside of Germany, spanning 27 countries around the globe.
With its activities in the areas of oncology, intensive care, and endocrinology, as well as its manufactured products, biosyn is a partner for clinics and registered doctors in private practices working in the area of integrative medicine, conventional medicine, and naturopathy.
Research and development are part of the staff’s responsibilities, as are the review of current medical and scientific literature and modern online marketing. The medium-sized family business attaches great importance to an open, committed, and customer-oriented corporate culture.
biosyn has been initiating and funding medical research for over 30 years. The importance of selenium in intensive care, oncology, and thyroid diseases plays a major role here.